191 related articles for article (PubMed ID: 27039312)
1. Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study.
Mishra N; Saxena S; Ruia S; Prasad S; Singh V; Khanna V; Staffa R; Gaspar L; Kruzliak P
J Diabetes Complications; 2016 Jul; 30(5):868-72. PubMed ID: 27039312
[TBL] [Abstract][Full Text] [Related]
2. Association of serum N(ε)-Carboxy methyl lysine with severity of diabetic retinopathy.
Mishra N; Saxena S; Shukla RK; Singh V; Meyer CH; Kruzliak P; Khanna VK
J Diabetes Complications; 2016 Apr; 30(3):511-7. PubMed ID: 26782022
[TBL] [Abstract][Full Text] [Related]
3. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
4. Resistive index of ophthalmic artery correlates with retinal pigment epithelial alterations on spectral domain optical coherence tomography in diabetic retinopathy.
Khatri M; Saxena S; Kaur A; Bhasker SK; Kumar M; Meyer CH
Int J Retina Vitreous; 2018; 4():12. PubMed ID: 29657836
[TBL] [Abstract][Full Text] [Related]
5. Anti-Vegf therapy leads to an improvement in grade of retinal pigment epithelium alterations on single layer retinal pigment epithelium map in diabetic macular edema.
Saxena S; Singh M; Chaubey A; Mohan A; De S; Kaur A; Gilhotra JS; Meyer CH; Akduman L
Eur J Ophthalmol; 2023 May; 33(3):1412-1417. PubMed ID: 36575598
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
Boehm BO; Schilling S; Rosinger S; Lang GE; Lang GK; Kientsch-Engel R; Stahl P
Diabetologia; 2004 Aug; 47(8):1376-9. PubMed ID: 15258735
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Tpl2 (Tumor Progression Locus 2) Inhibition on Diabetic Vasculopathy Through the Blockage of the Inflammasome Complex.
Sheu WH; Lin KH; Wang JS; Lai DW; Lee WJ; Lin FY; Chen PH; Chen CH; Yeh HY; Wu SM; Shen CC; Lee MR; Liu SH; Sheu ML
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e46-e62. PubMed ID: 33176446
[TBL] [Abstract][Full Text] [Related]
8. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations.
Sharma S; Saxena S; Srivastav K; Shukla RK; Mishra N; Meyer CH; Kruzliak P; Khanna VK
Clin Exp Ophthalmol; 2015 Jul; 43(5):429-36. PubMed ID: 25675974
[TBL] [Abstract][Full Text] [Related]
10. Antimyeloperoxidase antibody is a biomarker for progression of diabetic retinopathy.
Sinha S; Saxena S; Das S; Prasad S; Bhasker SK; Mahdi AA; Kruzliak P
J Diabetes Complications; 2016; 30(4):700-4. PubMed ID: 26948921
[TBL] [Abstract][Full Text] [Related]
11. Increased serum cortisol is associated with alterations in cross-sectional and topographic OCT parameters in diabetic retinopathy: a preliminary study.
Mohan A; Saxena S; De S; Kaur A; Ali W; Gilhotra JS; Meyer CH
Int Ophthalmol; 2021 Nov; 41(11):3623-3630. PubMed ID: 34189705
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Glycemic Control on Retinal Photoreceptor Layers and Retinal Pigment Epithelium in Patients With Type 2 Diabetes Without Diabetic Retinopathy: A Follow-Up Study.
Ishibashi F; Kosaka A; Tavakoli M
Front Endocrinol (Lausanne); 2021; 12():614161. PubMed ID: 33967950
[TBL] [Abstract][Full Text] [Related]
14. Association of serum levels of anti-myeloperoxidase antibody with retinal photoreceptor ellipsoid zone disruption in diabetic retinopathy.
Sinha S; Saxena S; Prasad S; Mahdi AA; Bhasker SK; Das S; Krasnik V; Caprnda M; Opatrilova R; Kruzliak P
J Diabetes Complications; 2017 May; 31(5):864-868. PubMed ID: 28279572
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy.
Zhang X; Lai Y; McCance DR; Uchida K; McDonald DM; Gardiner TA; Stitt AW; Curtis TM
Diabetologia; 2008 Sep; 51(9):1723-30. PubMed ID: 18587559
[TBL] [Abstract][Full Text] [Related]
16. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
[TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography Biomarkers of the Outer Blood-Retina Barrier in Patients with Diabetic Macular Oedema.
Damian I; Nicoara SD
J Diabetes Res; 2020; 2020():8880586. PubMed ID: 33110922
[TBL] [Abstract][Full Text] [Related]
18. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Hirata K; Kubo K
Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of N epsilon-(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes.
Hwang JS; Shin CH; Yang SW
Diabetes Obes Metab; 2005 May; 7(3):263-7. PubMed ID: 15811143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
